Literature DB >> 9499095

Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.

M Ciarlet1, M K Estes, C Barone, R F Ramig, M E Conner.   

Abstract

The main limitation of both the rabbit and mouse models of rotavirus infection is that human rotavirus (HRV) strains do not replicate efficiently in either animal. The identification of individual genes necessary for conferring replication competence in a heterologous host is important to an understanding of the host range restriction of rotavirus infections. We recently reported the identification of the P type of the spike protein VP4 of four lapine rotavirus strains as being P[14]. To determine whether VP4 is involved in host range restriction in rabbits, we evaluated infection in rotavirus antibody-free rabbits inoculated orally with two P[14] HRVs, PA169 (G6) and HAL1166 (G8), and with several other HRV strains and animal rotavirus strains of different P and G types. We also evaluated whether the parental rhesus rotavirus (RRV) (P5B[3], G3) and the derived RRV-HRV reassortant candidate vaccine strains RRV x D (G1), RRV x DS-1 (G2), and RRV x ST3 (G4) would productively infect rabbits. Based on virus shedding, limited replication was observed with the P[14] HRV strains and with the SA11 Cl3 (P[2], G3) and SA11 4F (P6[1], G3) animal rotavirus strains, compared to the homologous ALA strain (P[14], G3). However, even limited infection provided complete protection from rotavirus infection when rabbits were challenged orally 28 days postinoculation (DPI) with 10(3) 50% infective doses of ALA rabbit rotavirus. Other HRVs did not productively infect rabbits and provided no significant protection from challenge, in spite of occasional seroconversion. Simian RRV replicated as efficiently as lapine ALA rotavirus in rabbits and provided complete protection from ALA challenge. Live attenuated RRV reassortant vaccine strains resulted in no, limited, or productive infection of rabbits, but all rabbits were completely protected from heterotypic ALA challenge. The altered replication efficiency of the reassortants in rabbits suggests a role for VP7 in host range restriction. Also, our results suggest that VP4 may be involved in, but is not exclusively responsible for, host range restriction in the rabbit model. The replication efficiency of rotavirus in rabbits also is not controlled by the product of gene 5 (NSP1) alone, since a reassortant rotavirus with ALA gene 5 and all other genes from SA11 was more severely replication restricted than either parental rotavirus strain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499095      PMCID: PMC109534          DOI: 10.1128/JVI.72.3.2341-2351.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Serological and genomic characterization of equine rotavirus VP4 proteins identifies three different P serotypes.

Authors:  P Isa; D R Snodgrass
Journal:  Virology       Date:  1994-06       Impact factor: 3.616

2.  Comparative analysis of the rotavirus NS53 gene: conservation of basic and cysteine-rich regions in the protein and possible stem-loop structures in the RNA.

Authors:  J Hua; E A Mansell; J T Patton
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

3.  The outer capsid protein VP4 of murine rotavirus strain Eb represents a tentative new P type.

Authors:  M M Sereno; M I Gorziglia
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

Review 4.  Rotavirus vaccines and vaccination potential.

Authors:  M E Conner; D O Matson; M K Estes
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

5.  Comparison of the rotavirus nonstructural protein NSP1 (NS53) from different species by sequence analysis and northern blot hybridization.

Authors:  S J Dunn; T L Cross; H B Greenberg
Journal:  Virology       Date:  1994-08-15       Impact factor: 3.616

6.  Species specificity and interspecies relatedness in VP4 genotypes demonstrated by VP4 sequence analysis of equine, feline, and canine rotavirus strains.

Authors:  K Taniguchi; T Urasawa; S Urasawa
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

7.  The pathogenicity of two porcine rotaviruses differing in their in vitro growth characteristics and genes 4.

Authors:  J C Bridger; B Burke; G M Beards; U Desselberger
Journal:  J Gen Virol       Date:  1992-11       Impact factor: 3.891

8.  Identification of a new VP4 serotype of human rotaviruses.

Authors:  G Gerna; J Sears; Y Hoshino; A D Steele; O Nakagomi; A Sarasini; J Flores
Journal:  Virology       Date:  1994-04       Impact factor: 3.616

9.  Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence.

Authors:  R L Broome; P T Vo; R L Ward; H F Clark; H B Greenberg
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

10.  Rotavirus vaccine administered parenterally induces protective immunity.

Authors:  M E Conner; S E Crawford; C Barone; M K Estes
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more
  24 in total

1.  Milk Oligosaccharides Inhibit Human Rotavirus Infectivity in MA104 Cells.

Authors:  Daniel R Laucirica; Vassilis Triantis; Ruud Schoemaker; Mary K Estes; Sasirekha Ramani
Journal:  J Nutr       Date:  2017-06-21       Impact factor: 4.798

2.  Genome heterogeneity of SA11 rotavirus due to reassortment with "O" agent.

Authors:  Catie Small; Mario Barro; Thomas L Brown; John T Patton
Journal:  Virology       Date:  2006-10-23       Impact factor: 3.616

3.  Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype.

Authors:  Monica M McNeal; Karol Sestak; Anthony H-C Choi; Mitali Basu; Michael J Cole; Pyone P Aye; Rudolf P Bohm; Richard L Ward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection.

Authors:  Kapil Saxena; Lukas M Simon; Xi-Lei Zeng; Sarah E Blutt; Sue E Crawford; Narayan P Sastri; Umesh C Karandikar; Nadim J Ajami; Nicholas C Zachos; Olga Kovbasnjuk; Mark Donowitz; Margaret E Conner; Chad A Shaw; Mary K Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

5.  Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection.

Authors:  Max Ciarlet; Margaret E Conner; Milton J Finegold; Mary K Estes
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission.

Authors:  Jelle Matthijnssens; Mustafizur Rahman; Vito Martella; Yang Xuelei; Sofie De Vos; Karolien De Leener; Max Ciarlet; Canio Buonavoglia; Marc Van Ranst
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Molecular analysis of the VP7, VP4, VP6, NSP4, and NSP5/6 genes of a buffalo rotavirus strain: identification of the rare P[3] rhesus rotavirus-like VP4 gene allele.

Authors:  V Martella; M Ciarlet; A Pratelli; S Arista; V Terio; G Elia; A Cavalli; M Gentile; N Decaro; G Greco; M A Cafiero; M Tempesta; C Buonavoglia
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Rotavirus infection stimulates the Cl- reabsorption process across the intestinal brush-border membrane of young rabbits.

Authors:  Mathie Lorrot; Sandra Martin; Monique Vasseur
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.

Authors:  Sarah E Blutt; Sue E Crawford; Kelly L Warfield; Dorothy E Lewis; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.

Authors:  Jin-Tao Li; Jing Wei; Hong-Xia Guo; Jiang-Bo Han; Nan Ye; Hai-Yang He; Tian-Tian Yu; Yu-Zhang Wu
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.